K

Kaken Pharmaceutical Co Ltd
TSE:4521

Watchlist Manager
Kaken Pharmaceutical Co Ltd
TSE:4521
Watchlist
Price: 4 376 JPY 0.3% Market Closed
Market Cap: 165.7B JPY
Have any thoughts about
Kaken Pharmaceutical Co Ltd?
Write Note

Kaken Pharmaceutical Co Ltd
Other Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Kaken Pharmaceutical Co Ltd
Other Equity Peer Comparison

Comparables:
4502
4568
4578
4519
4503

Competitive Other Equity Analysis
Latest Figures & CAGR of Competitors

Company Other Equity CAGR 3Y CAGR 5Y CAGR 10Y
K
Kaken Pharmaceutical Co Ltd
TSE:4521
Other Equity
ÂĄ1.1B
CAGR 3-Years
111%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Takeda Pharmaceutical Co Ltd
TSE:4502
Other Equity
ÂĄ3.1T
CAGR 3-Years
103%
CAGR 5-Years
69%
CAGR 10-Years
23%
Daiichi Sankyo Co Ltd
TSE:4568
Other Equity
ÂĄ333.6B
CAGR 3-Years
45%
CAGR 5-Years
28%
CAGR 10-Years
11%
Otsuka Holdings Co Ltd
TSE:4578
Other Equity
ÂĄ380.5B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
36%
Chugai Pharmaceutical Co Ltd
TSE:4519
Other Equity
ÂĄ2B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
6%
Astellas Pharma Inc
TSE:4503
Other Equity
ÂĄ645.2B
CAGR 3-Years
56%
CAGR 5-Years
40%
CAGR 10-Years
17%

See Also

What is Kaken Pharmaceutical Co Ltd's Other Equity?
Other Equity
1.1B JPY

Based on the financial report for Jun 30, 2024, Kaken Pharmaceutical Co Ltd's Other Equity amounts to 1.1B JPY.

What is Kaken Pharmaceutical Co Ltd's Other Equity growth rate?
Other Equity CAGR 3Y
111%

Over the last year, the Other Equity growth was 576%. The average annual Other Equity growth rates for Kaken Pharmaceutical Co Ltd have been 111% over the past three years .

Back to Top